Key Dates

Related Announcements

RFA-HG-22-008 - Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)

RFA-HG-22-009 - Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed)

RFA-HG-22-010 - Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed)

NOT-HG-23-006 - Notice of Change in the Number of Disease Study Sites (DSSs) in RFA-HG-22-008 “Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)”

NOT-HG-23-007 - Notice of Change in the Number of Disease Study Sites (DSSs) in RFA-HG-22-009 “Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed)”

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The “Multi-Omics for Health and Disease Consortium” is a consortium involving three related RFAs (RFA-HG-22-008, RFA-HG-22-009, and RFA-HG-22-010). The purpose of this Notice is to describe the number of DSSs in RFA-HG-22-010 “Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed)” that will be funded as part of the Multi-Omics for Health and Disease Consortium. Text within the following subsection of Part 2. Section 1 -- "Background and Objectives" -- has been edited (in bold italics). The number of Disease Study Sites (DSSs) in RFA-HG-22-008 and RFA-HG-22-009 will be corrected in separate Notices (NOT-HG-23-006 and NOT-HG-23-007, respectively).

Answers to questions discussed during the recently held pre-application webinar, as well as the webinar recording and slides, are available at:https://www.genome.gov/event-calendar/pre-applicant-webinar-for-multi-omics-for-health-and-disease-consortium. They will further clarify the number of DSSs and provide additional details about the Consortium, including questions around the budget and sample size.

Currently reads

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Background and Objectives (Paragraph #5)

This FOA solicits applications to establish the DACC. RFA-HG-22-008 and RFA-HG-22-009 will establish DSSs and the OPC(s), respectively.

Modified to read

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Background and Objectives (Paragraph #5)

This FOA solicits applications to establish the DACC. RFA-HG-22-008 and RFA-HG-22-009 will establish up to 6 DSSs and the OPC(s), respectively.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:

Joannella Morales, Ph.D.
National Human Genome Research Institute (NHGRI)
Email: [email protected]